180 Life Sciences (ATNFW) Short Interest Ratio & Short Volume $0.0090 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends 180 Life Sciences Short Interest Data180 Life Sciences (ATNFW) has a short interest of 9,500 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 157,326 shares to cover all short positions.Current Short Interest9,500 sharesPrevious Short Interest9,500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$66.98Short Interest Ratio0.1 Days to CoverLast Record DateSeptember 30, 2024Today's Trading Volume14,346 sharesAverage Trading Volume157,326 sharesToday's Volume Vs. Average9% Short Selling 180 Life Sciences? Sign up to receive the latest short interest report for 180 Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATNFW Short Interest Over TimeATNFW Days to Cover Over TimeATNFW Percentage of Float Shorted Over Time Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 180 Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/20249,500 shares $66.98 No ChangeN/A0.1 $0.01 9/15/20249,500 shares $59.85 -15.9%N/A0.1 $0.01 8/31/202411,300 shares $109.61 -29.4%N/A0.1 $0.01 8/15/202416,000 shares $161.60 -29.5%N/A0.1 $0.01 7/31/202422,700 shares $229.25 -26.5%N/A0.1 $0.01 7/15/202430,900 shares $278.10 No ChangeN/A0.2 $0.01 Get the Latest News and Ratings for ATNFW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 4/15/20249,000 shares $73.80 -74.9%N/A0.2 $0.01 3/31/202435,900 shares $294.38 +298.9%N/A0.7 $0.01 3/15/20249,000 shares $90.00 -7.2%N/A0.2 $0.01 2/29/20249,700 shares $69.84 -17.8%N/A0.2 $0.01 2/15/202411,800 shares $103.84 +35.6%N/A0.2 $0.01 1/31/20248,700 shares $34.80 -2.3%N/A0.2 $0.00 1/15/20248,900 shares $50.73 +6.0%N/A0.3 $0.01 12/31/20238,400 shares $35.28 -1.2%N/A0.3 $0.00 12/15/20238,500 shares $51.85 -3.4%N/A0.4 $0.01 11/30/20238,800 shares $75.68 -19.3%N/A0.4 $0.01 11/15/202310,900 shares $109.00 +3.8%N/A0.5 $0.01 10/31/202310,500 shares $103.95 -1.9%N/A0.3 $0.01 10/15/202310,700 shares $111.28 -10.8%N/A0.3 $0.01 9/30/202312,000 shares $136.80 +41.2%N/A0.4 $0.01 9/15/20238,500 shares $130.05 +3.7%N/A0.2 $0.02 8/31/20238,200 shares $82.00 -24.8%N/A0.2 $0.01 8/15/202310,900 shares $78.48 +21.1%N/A0.3 $0.01 7/31/20239,000 shares $81.00 -23.1%N/A0.2 $0.01 7/15/202311,700 shares $117.00 -7.9%N/A0.3 $0.01 6/30/202312,700 shares $149.86 +11.4%N/A0.2 $0.01 6/15/202311,400 shares $151.62 -47.2%N/A0.1 $0.01 5/31/202321,600 shares $324.00 -22.6%N/A0.2 $0.02 5/15/202327,900 shares $359.91 No ChangeN/A0.3 $0.01 9/30/20228,300 shares $428.28 -35.7%N/A0.4 $0.05 9/15/202212,900 shares $1,225.50 +55.4%N/A0.7 $0.10 8/31/20228,300 shares $710.48 -38.5%N/A0.5 $0.09 8/15/202213,500 shares $1,929.14 -45.8%N/A0.8 $0.14 7/31/202224,900 shares $3,984.00 +69.4%N/A1.6 $0.16 7/15/202214,700 shares $2,578.37 +15.8%N/A0.9 $0.18 6/30/202212,700 shares $2,032.00 -52.3%N/A0.7 $0.16 6/15/202226,600 shares $5,639.20 +18.8%N/A1.4 $0.21 5/31/202222,400 shares $6,050.24 -30.7%N/A1 $0.27 5/15/202232,300 shares $8,937.93 +141.0%N/A1.3 $0.28 4/30/202213,400 shares $4,663.87 -25.1%N/A0.6 $0.35New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! 4/15/202217,900 shares $0.00 -9.1%N/A0.7 $0.00 ATNFW Short Interest - Frequently Asked Questions What is 180 Life Sciences' current short interest? Short interest is the volume of 180 Life Sciences shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 9,500 shares of ATNFW short. Learn More on 180 Life Sciences' current short interest. How does 180 Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 180 Life Sciences: Alvotech (0.07%), eFFECTOR Therapeutics, Inc. (16.84%), LAVA Therapeutics (0.13%), Mainz Biomed (8.71%), Pharvaris (0.76%), Procaps Group S.A. (0.11%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short 180 Life Sciences stock? Short selling ATNFW is an investing strategy that aims to generate trading profit from 180 Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 180 Life Sciences? A short squeeze for 180 Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNFW, which in turn drives the price of the stock up even further. How often is 180 Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNFW, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies ALVOW Short Interest Data ALVO Short Interest Data ACABW Short Interest Data BFRIW Short Interest Data BCTXW Short Interest Data CELUW Short Interest Data CLNNW Short Interest Data CYTHW Short Interest Data DRMAW Short Interest Data EFTR Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATNFW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
